When a company's stock price falls below a dollar, a mechanical countdown begins. The exchange sends a polite warning, the company executes a reverse split, the stock slides below a dollar again, and suddenly the grace periods vanish. It is a familiar rhythm in the micro-cap world, a steady march toward the OTC markets or bankruptcy court. This week, we saw the final movements of several long-playing symphonies of distress. We have pre-packaged zero-recoveries, a structural casualty begging its creditors for a few more weeks, and an auditor straight-up retracting its blessing. Let's look at the wreckage.
QVC Group (QVCGA): The Final Cut
The Filing: QVC Group received bankruptcy court confirmation of its Second Amended Joint Prepackaged Plan of Reorganization. Series A, Series B, and preferred stock will be canceled for absolutely zero consideration.
What Happened Since: Judge Alfredo Perez overruled objections from a group of preferred shareholders who lawyered up with Glenn Agre to fight the wipeout. They argued the plan was a "total capitulation" to the operating company. The judge disagreed. QVC Group will emerge with $1.3 billion in debt (down from $6.6 billion), and vendors are made whole. But if you held the old equity, you get a painful lesson in absolute priority. The funded debt holders—represented by Simpson Thacher and Davis Polk—are taking 100% of the reorganized equity. It is the classic pre-pack: bondholders get the keys, management gets new equity to stick around, and retail shareholders get a donut.
Sleep Number (SNBR): Kelce's Nightmare
The Filing: Bankrupt mattress maker Sleep Number entered an amended asset purchase agreement to sell substantially all of its assets to Sleep Country Canada for a revised cash price of $529.5 million.
What Happened Since: The bankruptcy court officially rubber-stamped the deal this week. Sleep Country Canada—which was taken private by Fairfax Financial—bumped its initial $415 million stalking horse bid up to $529.5 million. But a higher bid does not mean salvation for the equity. Even a highly publicized investment earlier this year from Travis Kelce couldn't stop the inevitable. Between 2020 and 2022, Sleep Number spent nearly $650 million on stock buybacks, borrowing heavily against its credit facility to fund them. Now, the assets head north, the stores stay open under new ownership, and SNBR equity holders are wiped out. A stark reminder that levering up to buy back stock at the peak of a pandemic boom is a terrible way to build a balance sheet.
FiscalNote (NOTE): The LLM Victim
The Filing: FiscalNote amended forbearance agreements with its subordinated creditors (GPO FN Noteholder and Yorkville), waiving defaults triggered by its NYSE delisting until August 22, 2026.
What Happened Since: FiscalNote is the poster child for the "SaaSpocalypse." They built a business as a middleman for structured policy and legislative data. Then large language models commoditized their core product. The NYSE pulled their listing in March after they failed to hold the $1 line. Since then, they have been trading on the OTCID and constantly begging creditors for one-month extensions on their debt defaults. The company insists it is entering a "new phase of health and opportunity" by launching a ChatGPT app integration, but creditors are not convinced. They only gave the company until late August before they can accelerate the debt. The clock is ticking very loudly.
FibroBiologics (FBLG): Out of Second Chances
The Filing: Nasdaq sent a staff determination to delist FibroBiologics for failing to maintain a $1.00 minimum bid price. Crucially, they are ineligible for the standard 180-day grace period because they executed a reverse stock split within the last year.
What Happened Since: Trading is slated to be suspended on July 31. The company plans to request a hearing before the Nasdaq panel to delay the execution, but it is a nearly impossible sell. FibroBiologics has zero revenue, massive cash burn, and a chart that looks like a cliff face. The Nasdaq escalator rules are unforgiving: if you do a reverse split to cure a bid price deficiency and then fall right back under a buck, you don't get another six months to figure it out. You get the boot.
American Resources Corp (AREC): The Un-Audited
The Filing: American Resources dismissed independent auditor GreenGrowth CPA and hired UHY LLP. This comes after GreenGrowth withdrew its audit opinion on the 2025 financials.
What Happened Since: This has been a slow-moving trainwreck. AREC missed its 10-K filing deadline back in April, with CEO Mark Jensen promising it was coming "very shortly." Instead, on July 3, GreenGrowth formally withdrew its 2025 opinion—a catastrophic red flag signaling the numbers can no longer be relied upon. The company admits to material weaknesses in internal controls but claims there were no "disagreements" with GreenGrowth. Now UHY LLP gets to start from scratch. If you are trading AREC right now, you are trading on pure imagination. The 2025 financials are officially fiction until UHY signs off.
What to Watch
August is setting up to be a brutal month for balance sheet restructurings. Watch FiscalNote as that August 22 forbearance deadline approaches—unless they find a white knight or a massive liquidity injection, Chapter 11 is the next logical step. Keep an eye on AREC's new auditors at UHY; if they uncover anything worse than standard internal control sloppiness, we could see severe restatements dating back years.